相关实验视频

Updated: May 5, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

用于改善脑瘤向和治疗的可定制弹性类聚链的刺激响应纳米粒子

Jinxia Huang¹, Yan Xia², Liping Wang²

¹Inner Mongolia Key Laboratory for Molecular Regulation of the Cell, School of Life Sciences, Inner Mongolia University, Hohhot 010020, China; Department of Neurovascular Center, Inner Mongolia People's Hospital, Hohhot 010021 Inner Mongolia, China.

International journal of pharmaceutics

|August 21, 2025

概括

研究人员开发了一种新型纳米平台,使用类弹性 (ELP) 来治疗质母细胞瘤. 该系统有效地通过血脑屏障传递药物,并在轻度高温时释放药物,在临床前模型中显示出有希望的结果.

科学领域:

生物材料科学
纳米技术
癌症学

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
由于透性生长和血脑屏障 (BBB),传统疗法面临挑战.
药物输送到大脑受到不透的BBB的阻碍.

研究的目的:

开发一种对刺激有反应的纳米平台,用于向质母细胞瘤药物.
为增强药物封装和控制释放设计基于弹性类 (ELP) 的纳米颗粒.
评估ELP纳米颗粒在克服BBB和治疗质母细胞瘤中的有效性.

主要方法:

具有不同ELP链长度的工程化化学多-多克索鲁比辛结合物 (L-CP-DOX NP).
根据药物封装和释放特性选择L-CP1200-DOXNP作为最佳配方.
使用瘤透LinTT1进行BBB穿越和轻度高温,以触发药物释放.
在正管质母细胞瘤模型中评估了纳米粒子积累,抗瘤功效和毒性.

主要成果:

L-CP1200-DOXNP显示了药物封装的增强和温度响应的释放.
在LinTT1的介导下,纳米颗粒有效地穿过BBB并向瘤组织.
轻度高温诱导了ELP1200阶段过渡,导致瘤特异性的多克索鲁释放.
在体内研究显示瘤积累增强,显著的抗瘤功效,并减少了非向性毒性.

结论:

基于ELP的纳米载体代表了针对热反应性脑瘤的多功能平台.
开发的纳米平台显示了基于蛋白质的药物输送系统在神经瘤学中的转化前景.
这种方法为克服BBB限制和改善质母细胞瘤治疗结果提供了潜在的策略.

关键词:

化学聚提供药物类似弹性质的多质瘤自组装纳米粒子热反应

更多相关视频

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...